During the past decade, Liberty Radiation Oncology Center conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 74 clinical trials were completed, i.e. on average, 296% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 40 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Liberty Radiation Oncology Center" #1 sponsor was "National Cancer Institute (NCI)" with 54 trials, followed by "SWOG Cancer Research Network" with 27 trials sponsored, "Alliance for Clinical Trials in Oncology" with 13 trials sponsored, "Gynecologic Oncology Group" with 8 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 8 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Liberty Radiation Oncology Center" #1 collaborator was "National Cancer Institute (NCI)" with 60 trials as a collaborator, "NRG Oncology" with 13 trials as a collaborator, "NCIC Clinical Trials Group" with 5 trials as a collaborator, "SWOG Cancer Research Network" with 5 trials as a collaborator and "Cancer and Leukemia Group B" with 4 trials as a collaborator. Other collaborators include 17 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Liberty Radiation Oncology Center" are "Breast Cancer" (9 trials), "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Lung Cancer" (5 trials) and "Colorectal Cancer" (4 trials). Many other conditions were trialed in "Liberty Radiation Oncology Center" in a lesser frequency.

Most popular intervention types in "Liberty Radiation Oncology Center" are "Drug" (95 trials), "Other" (78 trials), "Biological" (44 trials), "Procedure" (20 trials) and "Radiation" (14 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (58 trials), "Quality-of-Life Assessment" (27 trials), "Paclitaxel" (19 trials), "Bevacizumab" (16 trials) and "Carboplatin" (16 trials). Other intervention names were less common.

The vast majority of trials in "Liberty Radiation Oncology Center" are 86 trials for "All" genders and 28 trials for "Female" genders.

Currently, there are NaN active trials in "Liberty Radiation Oncology Center". undefined are not yet recruiting, 5 are recruiting, 55 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 46 completed trials in Liberty Radiation Oncology Center, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Liberty Radiation Oncology Center, 6 "Phase 1" clinical trials were conducted, 47 "Phase 2" clinical trials and 62 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".